Superior Vena Cava Syndrome Caused by Central Line, Pacemaker Wire, or ICD Lead
Clinical scenario
This protocol addresses benign superior vena cava (SVC) syndrome in patients where the obstruction is attributable to an implanted intravascular device — a central venous catheter, pacemaker wire, or implantable cardioverter-defibrillator (ICD) lead.
Because the cause is device-related rather than malignant, a targeted intervention directed at the offending device may be sufficient — without the broader systemic approaches required in other forms of SVC syndrome.
Treatment approach (partial)
Management in this setting focuses on addressing the causative implanted device or catheter. A catheter-based vascular procedure is typically part of the approach. The full procedural sequence, indications, and follow-up recommendations are available in the complete protocol.
References
DOI: 10.1016/j.jvsv.2026.102491
In some patients with benign disease, caused by central line, pacemaker wire, or implantable cardioverter-defibrillator lead, removal of the line or lead, usually with angioplasty alone, is all that is needed.
Current recommendations for lead-related SVC syndrome suggest transvenous lead extraction with angioplasty and stenting, and close follow-up for symptomatic restenosis if the lead must be reinserted.
View source ↗